Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ADMA
ADMA logo

ADMA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ADMA News

ADMA Biologics Shares Plunge 16% Amid Investigation

6h agoPRnewswire

ADMA Biologics Under Investigation for Securities Fraud

15h agoGlobenewswire

ADMA Biologics Shares Plunge 16% Amid Investigation

3d agoGlobenewswire

ADMA Biologics Under Investigation for Securities Violations

3d agoNewsfilter

Novartis Proposes Acquisition of Excellergy to Expand Immunology Pipeline

3d agoNASDAQ.COM

ADMA Biologics Faces Legal Investigation

3d agoGlobenewswire

ADMA Biologics Refutes Short Report Claims, Shares Surge

3d agoseekingalpha

ADMA Biologics Defends Against Short Report Claims

3d agostocktwits

ADMA Shares Climb 9% in Pre-Market Trading: Biologics Company Responds to Culper Short Report, Affirms Steady Growth of Asceniv

3d agostocktwits

ADMA Biologics Responds to Short Seller Report

3d agoNewsfilter

ADMA BIOLOGICS: DISPUTES MAJOR CLAIMS TO CLARIFY MARKET CONFUSION REGARDING ITS BUSINESS PRACTICES AND OPERATIONS

3d agomoomoo

Investigation into ADMA Biologics for Securities Violations

3d agoGlobenewswire

Health Care Stocks Decline Late Thursday

4d agoYahoo Finance

Surge in Options Trading Volume for ADMA Biologics

4d agoNASDAQ.COM

ADMA Biologics Under Investigation for Securities Compliance

4d agoGlobenewswire

ADMA Biologics Shares Decline Amid Downgrade

4d agoseekingalpha